Literature DB >> 3377007

Variable expression of autosomal recessive polycystic kidney disease and congenital hepatic fibrosis within a family.

B S Kaplan1, P Kaplan, J P de Chadarevian, S Jequier, S O'Regan, P Russo.   

Abstract

Blyth and Ockenden [1971] assigned patients with autosomal recessive polycystic kidney disease (ARPCKD) to 4 discrete groups (perinatal, neonatal, infantile, juvenile) on the basis of the age of presentation. They and others speculated that at least 4 genes were responsible for what they considered to be closely related, but different conditions. These views have gained wide but not universal acceptance. Some workers have insisted that the perinatal and neonatal "forms" of ARPCKD differ fundamentally from the juvenile "form." However, others have proposed that ARPCKD-CHF (congenital hepatic fibrosis) and CHF-ARPCKD are manifestations of the same disease with variation of expression in a kindred. We report on a patient who presented at birth (1979) with ARPCKD and respiratory distress. He died at 18 hr. An older sib presented at 16 yr in 1984. She had no symptoms, but her mother wanted reassurance that the daughter did not have a condition similar to that of the deceased sib. Blood pressure was 120/80 mm Hg and there was hepatosplenomegaly. A diagnosis of renal tubular ectasia and CHF was made by ultrasonography, radiologic studies, and a liver biopsy. The evidence from families such as this favors the concept that ARPCKD and CHF presenting as Blyth and Ockenden's perinatal form, and CHF and renal tubular ectasia as their juvenile form, are manifestations of the same genetic disorder, and that the different manifestations are more likely variations in expression than the results of different mutant genes. The manifestations in this family add weight to the growing body of evidence that intrafamilial variability may occur, not only in autosomal dominant conditions, but also in autosomal recessive disorders.

Entities:  

Mesh:

Year:  1988        PMID: 3377007     DOI: 10.1002/ajmg.1320290323

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 2.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

3.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

Review 4.  Renal cysts in pediatric patients. A classification and overview.

Authors:  J M Kissane
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

5.  Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease.

Authors:  Ramona Ajiri; Kathrin Burgmaier; Nurver Akinci; Ilse Broekaert; Anja Büscher; Ismail Dursun; Ali Duzova; Loai Akram Eid; Marc Fila; Michaela Gessner; Ibrahim Gokce; Laura Massella; Antonio Mastrangelo; Monika Miklaszewska; Larisa Prikhodina; Bruno Ranchin; Nadejda Ranguelov; Rina Rus; Lale Sever; Julia Thumfart; Lutz Thorsten Weber; Elke Wühl; Alev Yilmaz; Jörg Dötsch; Franz Schaefer; Max Christoph Liebau
Journal:  Kidney Int Rep       Date:  2022-05-04

6.  Autosomal recessive polycystic kidney disease.

Authors:  B S Kaplan; J Fay; V Shah; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

8.  Polycystic kidney and hepatic disease with mental retardation and hand anomalies in three siblings.

Authors:  Tomás Seeman; Marcela Malíková; Kveta Bláhová; Eva Seemanová
Journal:  Pediatr Nephrol       Date:  2008-11-15       Impact factor: 3.714

9.  Ex vivo modeling of chemical synergy in prenatal kidney cystogenesis.

Authors:  Corina Anders; Nick Ashton; Parisa Ranjzad; Mark R Dilworth; Adrian S Woolf
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

10.  Predicting mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies.

Authors:  Miao-Xin Li; Johnny S H Kwan; Su-Ying Bao; Wanling Yang; Shu-Leong Ho; Yong-Qiang Song; Pak C Sham
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.